PHI's strong financial position together with government initiatives are projected to bridge the financial effects of the COVID-19 pandemic well into 2021 with the current organization, if not all the way through 2021.

Read the commentary here.

For additional information, please contact:
Peter Egelberg
E-mail: ir@phiab.se
Web: www.phiab.com - Live cell imaging & analysis

Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.